RGRinat R. Gimadiev

Rinat R. Gimadiev

*This is an algorithmically generated author record based on publicly available information.

Rinat R. Gimadiev has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and experimental analysis of aldosterone concentrations in tear fluid and blood serum: Prospects for use as biomarkers in space medicine

    by M. O. Senchilov, O. M. Manko, G. Yu. Vassilieva, R. R. Gimadiev, М. О. Сенчилов, О. М. Манько, Г. Ю. Васильева, Р. Р. Гимадиев

    Clinical and experimental analysis of aldosterone concentrations in tear fluid and blood serum: Prospects for use as biomarkers in space medicine | Senchilov | Extreme Medicine Клинико-экспериментальный анализ содержания альдостерона в слезной жидкости и сыворотке крови: перспективы использования в качестве биомаркеров в космической медицине | Сенчилов | Экстремальная биомедицина

  • Open Access

    Impact of 365-day isolation on biogenic amine levels and headache-related biomarkers: A prospective cohort study

    by E. A. Sedov, G. Yu. Vassilieva, D. Yu. Kolesnikov, K. V. Gordienko, R. R. Gimadiev, Е. А. Седов, Г. Ю. Васильева, Д. Ю. Колесников, К. В. Гордиенко, Р. Р. Гимадиев

    Impact of 365-day isolation on biogenic amine levels and headache-related biomarkers: A prospective cohort study | Sedov | Extreme Medicine Влияние 365-суточной изоляции на концентрацию биогенных аминов и маркеров головной боли: проспективное когортное исследование | Седов | Экстремальная биомедицина

  • Comparative analysis of the effectiveness of iron therapy with a hepcidin-independent absorption mechanism in patients with chronic heart failure

    by A. A. Gurkina, N. I. Stuklov, V. A. Kokorin, R. R. Gimadiev, N. V. Varekha

    The aim of this study is to describe anemia in chronic heart failure (CHF) and to evaluate the effectiveness of oral therapy with sucrosomial iron (SiderAL® Forte) in this group. Material and methods. The study included 56 patients with CHF and anemia. Results. Anemia in CHF corresponds to anemia of chronic disease (ACD) with the development of iron deficiency (ID) in 75% of patients. The use of sucrosomial iron leads to a significant increase in hemoglobin and serum ferritin levels, a decrease in the concentration of N-terminal pro-brain natriuretic peptide, an improvement in exercise tolerance, a reduction in the functional class of CHF, and a decrease in mortality over a 2-year follow-up period. Conclusion. The addition of iron preparations with hepcidin-independent absorption to standard CHF therapy shows a significant positive effect across all criteria and can be recommended for this category of patients in routine clinical practice.

  • Open Access

    Development of a method for differential diagnosis of iron deficiency anemia and anemia of chronic disease based on demographic data and routine laboratory tests using machine learning technologies

    by N. V. Varekha, N. I. Stuklov, K. V. Gordienko, R. R. Gimadiev, O. B. Shchegolev, S. N. Kislaya, E. V. Gubina, A. A. Gurkina

    Background. The study of machine learning methods, a branch of artificial intelligence science, is relevant for the development of optimal screening strategies, identification of risk groups, and application of less expensive and more accessible laboratory tests to assess the body iron status. Aim. To select an appropriate artificial intelligence algorithm for predicting serum ferritin (SF) levels and to evaluate its applicability for differential diagnosis of iron deficiency anemia and anemia of chronic diseases. Materials and methods. A dataset of 9771 patients with micro‑normocytic anemia was used to create the model. On the basis of demographic data (gender and age), clinical blood count, C‑reactive protein level and known SF level, a regression model was developed to calculate the expected SF concentration in a particular patient and, using the same parameters, a classification model to determine the SF level group to which the patient belongs: I – 15 μg / L; II – 15–100 μg / L; III – 100–300 μg / L; Iv – ≥ 300 μg / L. Results. As a result, the regression model has moderate predictive ability (R2 = 0.70; median absolute error was 10.7 μg / L), the correlation coefficient between known and predicted SF level was r = 0.854 (p 0.05). The obtained classification model has high diagnostic accuracy for different clinical groups according to the SF level (AuC ROC was 0.91; 0.79; 0.84; 0.90 and 0.96; 0.76; 0.71; 0.82 for patients with reduced hemoglobin levels in women ( 120 g / L) and men ( 130 g / L) in groups I, II, III, Iv, respectively). Conclusion. Prediction of SF level using the developed models can be used as an accurate and clinically relevant tool for differential diagnosis of iron deficiency anemia (predicted SF is decreased ( 100 μg / L), C‑reactive protein is normal) and anemia of chronic diseases (predicted SF is normal or increased (100 μg / L), C‑reactive protein is increased) in real medical practice.


  • Open Access

    Correction of anemia using an iron supplement with a hepcidin-independent absorption mechanism in patients with chronic heart failure with preserved left ventricular ejection fraction

    by A. A. Gurkina, N. I. Stuklov, V. A. Kokorin, R. R. Gimadiev, N. V. Varekha

       Aim. To characterize anaemia in chronic heart failure (CHF) with preserved left ventricular ejection fraction (CHFpEF) and evaluate the effectiveness of an iron supplement with a hepcidin- independent absorption mechanism.   Material and methods. An uncontrolled study included 30 patients with CHFpEF NYHA class I-III and anaemia. Patients received "standard therapy" for CHF in combination with sucrosomial iron (60 mg/day orally) for three months. Treatment response was assessed via clinical blood test, iron metabolism parameters, inflammatory markers, and functional tests at baseline and three months post-treatment.   Results. Anaemia in CHFpEF corresponds to anaemia of chronic disease with elevated hepcidin content, 219 (149-553) ng/mL occurs with impaired absorption and metabolism of iron and the development of iron deficiency. Hemoglobin levelincreased from 115 (98-117) g/L to 120 (103-133) g/L, p = 0.01, red blood cell count increased from 3.6 (3.5-4.1) × 1012/L to 4 (3.7-5.3) × 1012/L, p = 0.05, and serum ferritin increased from 106 (40-181) μg/L to 117 (83-166) μg/L, p = 0.04. N-terminal natriuretic propeptide (NT-proBNP) level decreased from 374 (330-443) ng/mL to 236 (128-349) ng/mL, p = 0.004. After treatment, exercise tolerance exercise tolerance improved: 6-minute walk test distance increased from 343.1 ± 100 m to 397±73 m (p = 0.01). Quality of life (QoL) level increased and was determined by the clinical status assessment scale (CAS), p = 0.01 and by the Minnesota Health Failure Questionnaire (MHFLQ), p = 0.002.   Conclusion. Adding oral hepcidin- independent iron to standard HFpEF therapy in patients with CHFpEF and anaemia significantly increased hemoglobin and serum ferritin levels, exercise tolerance, and QoL scores while reducing NT-proBNP levels and NYHA functional class after three months.

  • Open Access

    Multidirectional effect of low-intensity neuromuscular electrical stimulation on gene expression and phenotype in thigh and calf muscles after one week of disuse

    by Anna A. Borzykh, Roman Y. Zhedyaev, Ivan I. Ponomarev, Tatiana F. Vepkhvadze, Viktor G. Zgoda, Mira A. Orlova, Nikita E. Vavilov, Nikita V. Shishkin, Egor M. Lednev, Pavel A. Makhnovskii, et al.

    Aim Low-intensity neuromuscular electrical stimulation was offered as a safe (non-traumatic) approach to prevent the loss of muscle mass, strength, and endurance in patients with severe chronic diseases and in spaceflight. However, the effects of this approach on various leg muscles are poorly investigated. Methods This study assessed the efficiency of low-intensity (∼10% of maximal voluntary contraction) electrical stimulation in preventing the negative effects of weekly disuse (dry immersion without and with daily stimulation) on the strength and aerobic performance of the ankle plantar flexors and knee extensors, mitochondrial function in permeabilized muscle fibers, and the proteomic (quantitative mass spectrometry-based analysis) and transcriptomic (RNA-sequencing) profiles of the soleus muscle and vastus lateralis muscle. Results Application of electrical stimulation during dry immersion prevented a decrease in the maximal strength and a slight reduction in aerobic performance of knee extensors, as well as a decrease in maximal (intrinsic) ADP-stimulated mitochondrial respiration and changes in the expression of genes encoding mitochondrial, extracellular matrix, and membrane proteins in the vastus lateralis muscle. In contrast, for the ankle plantar flexors/soleus muscle, electrical stimulation had a positive effect only on maximal mitochondrial respiration, but accelerated the decline in the maximal strength and muscle fiber cross-sectional area, which appears to be related to the activation of inflammatory genes. Conclusion The data obtained open up broad prospects for the use of low-intensity electrical stimulation to prevent the negative effects of disuse for “mixed” muscles, meanwhile, the optimization of the stimulation protocol is required for “slow” muscles. Practitioner Points Low-intensity electrical myostimulation is often used as an alternative to exercise and high-intensity electrical stimulation to prevent the loss of muscle mass and function in patients with severe chronic diseases and in spaceflight. However, its effect on muscles with different functional capacities remains uncertain. One week of disuse (dry immersion) lead to a comparable decrease in the maximal strength and (intrinsic) mitochondrial respiration in both the ankle plantar flexors/soleus muscle and the knee extensors/vastus lateralis muscle. Meanwhile changes in gene expression (transcriptome) were three times more pronounced in the soleus muscle than in the vastus lateralis muscle. Application of electrical stimulation during disuse prevented most of the negative effects of disuse in the knee extensors/vastus lateralis muscle, but accelerated the decline in the maximal strength/muscle fiber cross-sectional area in the ankle plantar flexors/soleus muscle, which may be related to the activation of genes regulating the inflammatory response.


  • Open Access

    New possibilities of pathogenetic correction of anemia in chronic heart failure

    by A. A. Gurkina, N. I. Stuklov, N. D. Kislyj, R. R. Gimadiev, A. A. Strel’nIkov

    If chronic heart failure (CHF) is accompanied by anemic syndrome and iron defi ciency (ID) tolerance to treatment develops, the eff ectiveness of drugs that form the basis of CHF treatment decreases, and the prognosis worsens. Aim. To evaluate the possibilities of using iron preparations with hepcidin-independent absorption mechanism depending on the characteristics of iron metabolism, erythropoiesis and the level of infl ammation in patients with CHF and anemia. Material and methods. The study included 68 patients diagnosed with CHF to describe the characteristics of anemia (General group). Further, 56 patients who signed consent to the study were divided into two groups: 30 patients (Treatment Group) with standard CHF therapy and iron preparations, and 26 (Comparison Group) with standard CHF therapy only. Sucrosomial iron (SI) was used 60 mg per day orally for three months. Results. Variants of anemia in CHF: absolute ID (AID) — 43%, functional ID (FID) — 19%, anemia without ID — 38%. In the treatment group, an increase in hemoglobin (Hb, p < 0.002), hematocrit (Ht, p < 0.001), mean corpuscular volume (MCV, p < 0.002) and serum ferritin (SF, p < 0.05), in the Сomparison group only Ht, p < 0.01, and the greatest increase in Hb was detected in patients with SF < 30 μmol/l (p < 0.002). Conclusion. Anemia in CHF corresponds to the signs of anemia of chronic disease (ACD) with J, while J was detected in 62% of patients. The use of SI signifi cantly increases erythrocyte counts and SF/


  • Open Access

    Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation

    by A. A. Gurkina, N. I. Stuklov, Н. Д. Кислый, R. R. Gimadiev, M. S. Kovalchuk

    Aim. To determine the characteristics of erythrocyte parameters, iron metabolism, erythropoiesis, inflammation markers in patients with heart failure (CHF) and anemia.Material and methods. The study included 68 patients with HF to describe the characteristics of anemia (general group). Patients of the general group were divided into 3 subgroups depending on the serum ferritin (SF) and transferrin saturation (TS).Results. Anemia in HF is not always associated with iron deficiency (ID), characterized by inadequate production of erythropoietin, increased levels of C-reactive protein and hepcidin. From the general group of patients, the following were distinguished: absolute ID (43%), functional ID (19%), and non-ID anemia (38%).Conclusion. In the general group of patients with HF, anemia is normochromic, normocytic, characterized by high levels of C-reactive protein, hepcidin, and inadequate production of erythropoietin. Patients with absolute and functional ID do not differ in the main iron metabolism parameters and in general account for 62% (p=0,01). In these two subgroups, iron supplements should be prescribed at further stages.


  • Open Access

    Acute decompensated heart failure. What has changed in the clinical guidelines in 2021?

    by Igor V. Zhirov, Svetlana N. Nasonova, Ulia A. Khalilova, Yulia F. Osmolovskaya, Irina A. Zhirova, Rinat R. Gimadiev, Olga Ia. Chaikovskaia, Oleg M. Reitblat, Iuliia Sh. Prints, Anatoly G. Kochetov, et al.

    In September 2021, the European Society of Cardiology issued new guidelines on the management of patients with heart failure (HF). In the current version, experts have focused on the 4 most common variants: acute HF decompensation, acute pulmonary edema, cardiogenic shock, and isolated right ventricular failure. There has been a change in approaches to the initial management of patients with acute HF decompensation towards a decrease in the evidence-based use of peripheral vasodilators and a "return" to loop diuretics as the basis of treatment. This raises the question of monitoring the efficacy of diuretic therapy. The paper presents an algorithm proposed by the European Society of Cardiology.


  • Open Access

    Acute heart failure: classification, diagnosis, general approaches to treatment

    by Igor V. Zhirov, Svetlana N. Nasonova, Ulkiar A. Khalilova, Yulia F. Osmolovskaya, Olga Ia. Chaikovskaia, Irina A. Zhirova, Rinat R. Gimadiev, Anatolii G. Kochetov, Sergei N. Tereshchenko, Халилова Улькяр Алимирзаевна, et al.

    Acute heart failure (HF) is a syndrome requiring urgent treatment. Due to drastic increase in the number of HF patients this problem is still of great importance for modern public health care and has a significant impact on morbidity and mortality. This article presents modern approaches to the classification of this condition, describes diagnostic algorithms, and discovers general methods of acute HF therapy. Two clinical axes are described the presence of stasis in one or two circuits of blood circulation and peripheral hypoperfusion, on the basis of which the individual approaches to treatment strategy of patients with this symptom complex are developed.